About CoMPaSS-NMD

This author has not yet filled in any details.
So far CoMPaSS-NMD has created 45 blog entries.

New Open-Access Publication: Inside the CoMPaSS-NMD Atlas Platform

By |2026-11-13T09:21:05+00:00November 13, 2026|News|

We are pleased to announce the publication of our latest paper, "The CoMPaSS-NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders," in the European Journal of Neurology (Special Issue on Digital Health Research in Clinical Neurosciences). Why We Built the Atlas Hereditary [...]

CoMPaSS-NMD at the 2nd AI4LUNGS Synergy Meeting: Advancing Clinical Interpretability in AI-Driven Healthcare

By |2026-11-13T09:16:12+00:00November 4, 2026|Events|

Healthcare innovation rarely advances in isolation. While individual European research consortia target specific pathologies, they frequently encounter identical hurdles: managing complex, heterogeneous datasets, validating predictive models against rigorous medical standards, and integrating algorithmic recommendations into real-world clinical routines. On October 21, the CoMPaSS-NMD project joined 9 fellow EU-funded consortia and 35 technical and clinical [...]

Open Workshop Announcement: Charting the Course – Next-Gen Discoveries in CoMPaSS-NMD

By |2026-09-07T12:37:29+00:00August 31, 2026|Events|

The CoMPaSS-NMD open workshop, "Charting the Course: Next-Gen Discoveries in CoMPaSS-NMD," took place on September 3rd, 2026, from 14:00 to 16:30 (CEST). Hosted in a hybrid format at Politechnika Śląska (SUT) in Gliwice, Poland, as well as online, this event highlighted the vital contributions of the early-career researchers driving innovation within the CoMPaSS-NMD project. [...]

CoMPaSS-NMD Featured in the Latest Issue of Projects Magazine

By |2026-07-14T12:59:08+00:00July 14, 2026|blog post|

We are thrilled to announce that CoMPaSS-NMD has been featured in a major spotlight article in the latest issue of Projects Magazine, published by research dissemination agency Insight Media. The feature, titled "COMPASS-NMD: Structuring uncertainty in neuromuscular disease," explores how our Horizon Europe-funded consortium is redefining the diagnostic and clinical landscape for patients living [...]

Italy Leads the Way in Europe: CoMPaSS-NMD Steers the AI Revolution for Neuromuscular Disorders

By |2026-06-17T07:12:38+00:00June 17, 2026|blog post|

The timing couldn't be more perfect. On June 16, 2026, the newly published "Rome Charter on Rare Diseases" made headlines, signaling Italy’s bid to steer the European Union toward equal health access, structured public-private networks, and unified data sharing for 30 million rare disease patients. But a charter is a vision—a political and strategic [...]

ASERMUDE: Supporting People with Neuromuscular Diseases and Driving Research Forward

By , , |2026-06-10T14:58:15+00:00June 10, 2026|blog post|

A patient-led association is helping improve lives and accelerate research into rare neuromuscular diseases. The Association ASERMUDE is a Spanish non-profit organization that works to improve the quality of life of people affected by neuromuscular diseases and their families. Its work focuses on providing comprehensive support, reliable information, and ongoing guidance to those living [...]

AI in NMD diagnosis: an allay for doctors and patients

By , |2026-06-16T08:05:56+00:00May 16, 2026|blog post|

Artificial intelligence, or AI, is a broad term for computer systems that can perform tasks that usually require human thinking, such as recognizing patterns, organizing information, and supporting decisions. Machine learning is one of the main approaches within AI. It allows computers to learn from data and improve over time, rather than simply following [...]

Neuromuscular Diagnosis: Insights from the CoMPaSS-NMD Atlas Webinar

By , |2026-04-20T08:47:57+00:00April 20, 2026|blog post, Events|

The journey to a diagnosis for rare neuromuscular diseases (NMDs) is often a long and difficult one. Patients frequently navigate a complex "diagnostic journey" that can stretch over years, involving a myriad of tests—from MRIs and biopsies to genetic screening—often scattered across different departments and timeframes. In December, the fourth CoMPaSS-NMD webinar introduced a [...]

External Validation Begins: The CoMPaSS-NMD ATLAS Platform Meets the Scientific Advisory Board

By |2026-04-15T07:53:16+00:00April 15, 2026|Events, News|

This week marks a major milestone in the evolution of the CoMPaSS-NMD project. On Thursday, April 16th, and Friday, April 17th, our consortium will host two critical workshops to present the ATLAS Platform to our international Scientific Advisory Board (SAB) for its first external expert evaluation. Until now, the ATLAS has undergone rigorous internal [...]

The Grand Finale: Joining the CoMPaSS-NMD ATLAS Webinar

By |2026-03-23T09:28:59+00:00March 2, 2026|Events, News|

The CoMPaSS-NMD project is reaching a major milestone in its Young Investigator Training (YIT) initiative. On April 21, 2026, we will host our fifth and final webinar: "The CoMPaSS-NMD ATLAS: A New Tool for Clinicians and Researchers." Neuromuscular diseases (NMDs) are often rare and heterogeneous, with similar phenotypes hiding different underlying mechanisms. The CoMPaSS-NMD [...]

Go to Top